Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2005Clinical Infectious DiseasesOpen Access

Control of Vancomycin‐Resistant Enterococci: One Size Fits All?

View Full Paper
Ask AI
Bookmark
Share

Authors

EAEmilian ArmeanuCenters for Disease Control and Prevention
Marc J. M. Bonten
Marc J. M. BontenManhattan Institute for Policy Research

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Armeanu et al. (2005) studied this question.

synapsesocial.com/papers/69dec572488ed2d92be93c67https://doi.org/10.1086/431206
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Vitro Antienterococcal Activity Explains Associations between Exposures to Antimicrobial Agents and Risk of Colonization by Multiresistant Enterococci2004 · 30 citations
  2. 2Nosocomial Spread of Linezolid-Resistant, Vancomycin-ResistantEnterococcus faecium2002 · 242 citations
  3. 3Projected Benefits of Active Surveillance for Vancomycin‐Resistant Enterococci in Intensive Care Units2004 · 109 citations
  4. 4An agent-based and spatially explicit model of pathogen dissemination in the intensive care unit*2005 · 66 citations
  5. 5Preventing the Influx of Vancomycin‐Resistant Enterococci into Health Care Institutions, by Use of a Simple Validated Prediction Rule2004 · 68 citations